DO.fm
Innovations in Type 1 Diabetes
12:47
Jay Shubrook, DO, FAAFP, FACOFP, discusses Type 1 diabetes (T1D). He delves into the importance of screening, early intervention, and patient-centered care. He also addresses the increasing prevalence in adults and modern technologies that are aiding T1D treatment.
Dr. Shubrook discloses relationships with Abbott, Bayer, and Novo Nordisk as a non-CE consultant and AstraZeneca, Eli Lilly, and…